Susie Harris of Parkwalk explains the firm's specialist approach to investing in technology businesses emerging from the UK's leading universities. Parkwalk was established in 2009 and focuses exclusively on university spinouts and technology businesses. Susie explains how the firm's different funds can support companies from very early-stage investment through to later-stage growth, with the wider IP Group network and co-investors providing additional capital as businesses develop. The presentation also covers Parkwalk's EIS Opportunities and Knowledge Intensive EIS funds, including portfolio construction and the EIS administration associated with each approach. In the Q&A, chaired by Steve Dobson of GrowthInvest, Susie discusses portfolio reporting and valuations, the challenges and opportunities in the Cambridge investment ecosystem, competition for university spinouts and the importance of Parkwalk's long-standing relationships with universities and entrepreneurs. Watch the full event on-demand: https://us06web.zoom.us/webinar/register/1017829083259/WN_3lPsCebMRvCmdzG3JUKxAA Read more on our website and check out our fund reviews here: https://hardmanandco.com/research/tax-advantaged-research/ Key topics covered: Parkwalk Advisors EIS investing University spinouts Deep tech University technology transfer UK innovation Early-stage investing EIS portfolio construction Knowledge Intensive Companies Portfolio reporting and valuations Cambridge investment ecosystem Deal flow University relationships Investment exits September 2026 Tax Advantaged Forum: Susie Harris, Director, Business Development at Parkwalk, was speaking at Hardman & Co's Tax Advantaged Forum, hosted in association with GrowthInvest. We also heard from EverQuest Capital Partners, MMC Ventures and PXN Investments. Important notice: This content has been prepared purely for information purposes, and should not be construed as an offer, or the solicitation of an offer, to buy or sell any security, product, service or investment. Nor should it be viewed as a substitute for viewers’ own due diligence. The companies or legal entities covered in this content may or may not pay us a fixed fee for this content to be made available. This content contains factually correct information at the time of publication which has been provided to us by our client to which the content relates, who have also confirmed that it has not been misleadingly presented. Investing in early-stage growth companies is speculative and involves a high degree of risk. An investor could lose all or a substantial amount of his or her investment, and the securities, legal entities or alternative investments mentioned in this content may not be suitable or appropriate for all investors. Access to liquidity may be totally or highly restricted. Each investor’s particular needs, investment objectives and financial situation were not taken into account in the preparation of this content. Each investor must make his or her own independent decisions and obtain their own independent advice regarding any information, projects, securities, tax treatment or financial instruments mentioned herein. The fact that Hardman & Co has made available through this content various information constitutes neither a recommendation to enter into a particular transaction nor a representation that any financial instrument is suitable or appropriate for you. Each investor should consider whether an investment strategy of the purchase or sale of any product or security is appropriate for them in the light of their investment needs, objectives and financial circumstances. For more information, please read our full disclaimers: www.hardmanandco.com/research-disclosures www.hardmanandco.com/disclaimer #EIS #EISInvesting #VentureCapital #UniversitySpinouts #DeepTech #UKInnovation #TechnologyInvesting #Parkwalk #Cambridge
